Singapore markets close in 7 hours 1 minute

iX Biopharma Ltd. (42C.SI)

SES - SES Delayed Price. Currency in SGD
Add to watchlist
0.2500-0.0050 (-1.96%)
As of 9:44AM SGT. Market open.
Show:
Income statement
Balance sheet
Cash flow
Annual
Premium required to access quarterly data
Quarterly

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2020
30/06/2019
30/06/2018
30/06/2017
Total revenue
985
985
671
6,533
6,381
Cost of revenue
1,572
1,572
1,200
5,156
4,448
Gross profit
-587
-587
-529
1,377
1,933
Operating expenses
Research development
2,499
2,499
3,765
8,031
4,811
Selling general and administrative
8,605
8,605
7,845
8,673
7,593
Total operating expenses
10,448
10,448
11,386
15,480
10,467
Operating income or loss
-11,035
-11,035
-11,915
-14,103
-8,534
Interest expense
238
238
232
267
242
Income before tax
-10,499
-10,499
-13,268
-15,155
-7,581
Income tax expense
0
0
-22
-61
-191
Income from continuing operations
-10,499
-10,499
-13,246
-15,094
-7,390
Net income
-10,499
-10,499
-2,991
-15,094
-7,390
Net income available to common shareholders
-10,499
-10,499
-2,991
-15,094
-7,390
Basic EPS
-
-
-0.00
-0.02
-0.01
Diluted EPS
-
-
-0.00
-0.02
-0.01
Basic average shares
-
-
643,830
641,549
638,406
Diluted average shares
-
-
647,930
641,549
638,406
EBITDA
-
-9,212
-11,820
-13,481
-6,058